Barclays’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-2,332,719
Closed -$2.07M 5533
2022
Q4
$2.07M Buy
2,332,719
+337,068
+17% +$447K ﹤0.01% 2243
2022
Q3
$3.13M Buy
1,995,651
+1,829,031
+1,098% +$4.15M ﹤0.01% 1448
2022
Q2
$335K Buy
166,620
+115,761
+228% +$200K ﹤0.01% 3121
2022
Q1
$118K Sell
50,859
-327,570
-87% -$1.02M ﹤0.01% 3709
2021
Q4
$1.76M Buy
378,429
+242,451
+178% +$1.51M ﹤0.01% 2466
2021
Q3
$1.04M Buy
135,978
+93,676
+221% +$794K ﹤0.01% 2766
2021
Q2
$410K Sell
42,302
-167,596
-80% -$1.33M ﹤0.01% 3186
2021
Q1
$1.74M Sell
209,898
-121,206
-37% -$1.28M ﹤0.01% 2402
2020
Q4
$2.26M Sell
331,104
-27,759
-8% -$223K ﹤0.01% 2141
2020
Q3
$4M Sell
358,863
-25,413
-7% -$233K ﹤0.01% 1551
2020
Q2
$2.41M Buy
384,276
+172,071
+81% +$659K ﹤0.01% 1939
2020
Q1
$391K Buy
212,205
+520
+0.2% +$1.5K ﹤0.01% 3783
2019
Q4
$716K Buy
211,685
+116,107
+121% +$277K ﹤0.01% 3971
2019
Q3
$205K Buy
95,578
+20,162
+27% +$47K ﹤0.01% 4951
2019
Q2
$201K Buy
75,416
+42,985
+133% +$155K ﹤0.01% 5105
2019
Q1
$154K Sell
32,431
-71,241
-69% -$187K ﹤0.01% 5031
2018
Q4
$249K Buy
103,672
+22,157
+27% +$72.4K ﹤0.01% 4434
2018
Q3
$359K Buy
81,515
+44,436
+120% +$246K ﹤0.01% 4539
2018
Q2
$267K Sell
37,079
-68,421
-65% -$465K ﹤0.01% 4484
2018
Q1
$543K Sell
105,500
-4,644
-4% -$33K ﹤0.01% 3895
2017
Q4
$419K Buy
110,144
+79,444
+259% +$207K ﹤0.01% 4034
2017
Q3
$52K Buy
30,700
+3,700
+14% +$6.79K ﹤0.01% 5335
2017
Q2
$54K Buy
27,000
+25,532
+1,739% +$49.8K ﹤0.01% 5317
2017
Q1
$6K Buy
1,468
+822
+127% +$4.12K ﹤0.01% 6246
2016
Q4
$3K Buy
+646
New +$3.88K ﹤0.01% 6287
2014
Q3
Sell
-1,000
Closed -$6K 7894
2014
Q2
$6K Buy
+1,000
New +$7.54K ﹤0.01% 7080

Other funds holding SRNE